Month: August 2021

Libervant™ NDA resubmission accepted, PDUFA goal date of December 23, 2021 On track to report top-line data from Phase 1 study for AQST-109 epinephrine sublingual film in second half 2021 Increases full year revenue guidance Hosts conference call at 8:00 a.m. ET on August 4, 2021WARREN, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today reported financial results for the second quarter ended June 30, 2021 and provided an update on recent developments in its business. “We continue to make progress, as committed, on the key value drivers for Aquestive. The FDA has accepted for filing the NDA for Libervant and assigned a PDUFA target goal...

MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Helen Hovenga has joined the Telix executive team in the role of Chief People Officer (CPO). Helen joins from the Peter MacCallum Cancer Centre where she was Executive Director of People and Culture, overseeing 3,500 health practitioners and research employees. Helen brings over 25 years’ experience in global human resources and business, gained across large multinationals, private equity firms, and ASX listed companies. Her sector experience spans public health, finance, manufacturing, mining, automotive and retail, with household names including Afterpay, Coles, Mars, Myer, Newcrest, Toyota and VicSuper. Helen holds a Master of Business (HR) from Charles Sturt University, a Graduate...

VANCOUVER, British Columbia, Aug. 03, 2021 (GLOBE NEWSWIRE) — Gold Standard Ventures Corp. (NYSE AMERICAN: GSV) (TSX: GSV) (“Gold Standard” or the “Company”) today announced drill results from reverse circulation (“RC”) holes and core drilling during 2020 at the POD and Sweet Hollow oxide gold deposits and a Central Bullion skarn target. Key Exploration Highlights:21 RC drill holes were completed as step outs to the current oxide resources at POD and Sweet Hollow. The oxide mineralization result reported in RR20-04 (12.1m @ 2.07 g Au/t) extends known mineralization by 30 to 60 meters. Elevated silver grades were encountered in the drilling of up to 130 g Ag/t. Currently, silver is not modeled in the resources at POD and Sweet Hollow. Five drill holes were completed at the historical Central Bullion mining district, focused on...

VANCOUVER, British Columbia, Aug. 03, 2021 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”, “the Company”, “we”, “our” or “us”) reported second quarter 2021 results today. All monetary amounts are in Canadian dollars unless otherwise stated. HIGHLIGHTSAll comparisons are to Q2 2020 results unless indicated otherwise.Q2 2021 EPS(1) of $0.56 per share was a record second quarter EPS performance. Q2 2021 revenue of $1.8 billion and net revenue(2) of $1.7 billion were up 30% and 28%, respectively, from Q2 2020 which was impacted by COVID-19-related reduction in market activity. Compared to Q1 2021, net revenue was up 16%, driven by strong recovery in new equipment demand in all regions and market sectors. Q2 2021 SG&A(1) as a percentage of net revenue(2) was 18.3%, reflecting savings from our 2020 cost reduction...

TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” or “Avicanna”) (TSX: AVCN) announces that the Ontario Securities Commission (“OSC“) has issued an order dated July 30, 2021 (the “Partial Revocation Order”) partially revoking the failure-to-file cease trade order issued against the Company on June 11, 2021 (the “FFCTO“) for failing to file certain outstanding continuous disclosure documents (collectively, the “Documents”) within the timeframes prescribed by applicable securities laws. The Partial Revocation Order permits the Company to conduct a financing on a private placement basis (the “Proposed Financing”). The FFCTO continues to apply in all other respects. Pursuant to the terms of the Proposed Financing, one or more investors (each, an “Investor”) may advance between $1,000,000...

Second Quarter Net Sales Increase 27% to $68.2 million Versus Q2 2020 On Track to Deliver Topline Results for Late-Stage Musculoskeletal Pipeline in Late Summer Company to Host Conference Call on August 4, 2021, at 8:30 AM ET MARIETTA, Ga., Aug. 03, 2021 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced the filing of its second quarter 2021 Form 10-Q for the period ended June 30, 2021. Timothy R. Wright, MIMEDX Chief Executive Officer, commented, “Our expanded commercial team is working aggressively toward the goal of achieving above-market growth for our Advanced Wound Care business, and executing on multiple initiatives that reinforce the differentiation of our products and convey the clinical...

TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) — The Board of Directors of Cerro Grande Mining Corporation (the “Company” or “CEG”) (CSE:CEG) regretfully announces with great sadness that Mr. Stephen W. Houghton, the former Chief Executive Officer of the Company until his retirement on March 31, 2021, who remained the President, on an unpaid basis and without day-to-day responsibilities, and a director of the Company, passed away on August 2, 2021 in Santiago, Chile. Mr. Houghton was instrumental in the creation and development of the Company and served as a director and officer of the Company since its beginnings. In addition to his contributions to the Company as an officer and director, Stephen was a man of character, a friend and colleague to many at CEG, who dedicated all his energies to the Company. Paul DesLauriers, the Chairman...

PLANO, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) — Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions provider for U.S.-based financial institutions, announced today that company leadership will participate at the following upcoming investor conferences:KeyBanc Capital Markets – Future of Technology Series, August 10, 2021. Chief Executive Officer Mike Hansen, Chief Financial Officer Bryan Hill and Vice President of Investor Relations Rhett Butler will present. Needham & Company – 3rd Annual Virtual FinTech & Digital Transformation 1×1 Conference, August 18, 2021. Chief Financial Officer Bryan Hill and Vice President of Investor Relations Rhett Butler will host one-on-one meetings.A webcast of the company’s presentation from the KeyBanc Capital Markets event...

MARYSVILLE, Ohio, Aug. 03, 2021 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), one of the world’s leading marketers of branded consumer lawn and garden as well as hydroponic and indoor growing products, announced that Gerald (Jerry) Volas has been named to its Board of Directors. Mr. Volas served as Chief Executive Officer and a director of TopBuild Corp., a leading installer and distributor of insulation products, between June 2015 and December 2020. “Jerry’s extensive operational leadership and experience with a wide-range of financial issues will be a benefit to our Company,” said Jim Hagedorn, chairman and chief executive officer. “He is a seasoned professional and I am confident that his voice on the Board will help bring continued value for our shareholders. On behalf of all the directors, I welcome him to...

Presented twelve-month data from ongoing AL001 open-label Phase 2 study in FTD-GRN at the 2021 Alzheimer’s Association International Conference (AAIC) Announced global collaboration with GSK to co-develop and co-commercialize progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range of neurodegenerative diseases SOUTH SAN FRANCISCO, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today reported financial results for the second quarter 2021. As of June 30, 2021, Alector’s cash, cash equivalents and investments totaled $319.6 million. “With the recent presentation of encouraging Phase 2 data for our lead program, AL001 in people with FTD-GRN, at the Alzheimer’s Association International Conference and our announcement of a significant...